+86-571-8627 3270
Changzhou Kony Pharmaceutical Co., Ltd.
38 YRS
Jiangsu, China
CNY 14.9 Million
66600 m²
100-500 people
Main Products: Valacyclovir HCl / Acyclovir / Famciclovir / Ganciclovir / Valganciclovir Hydrochloride / Valsartan / Rabeprazole Sodium / Ciclopirox
Jiangsu, China
ABOUT US
Founded in 1986, the company is a professional manufacturer of APIs and pharmaceutical intermediates. In 2008, it was renamed Changzhou Kangli Pharmaceutical Co., Ltd. In 2012, it became a member enterprise of Shanghai Pharmaceutical Group (601607. Sh, 02607. HK). It was renamed as Shangyao Kangli (Changzhou) Pharmaceutical Co., Ltd. in 2015. Its nucleoside antiviral raw materials and intermediates, and sartan antihypertensive raw materials and intermediates have a large output and a wide variety in China. The company is located in the water town of Jiangnan and the shore of Taihu Lake, covering an area of 65000 square meters, with fixed assets of more than 50 million yuan and more than 240 employees, of which scientific and technological personnel account for 20%. The company organizes production in strict accordance with GMP, has complete production and scientific research equipment, has a number of imported advanced testing equipment, has stable product quality, is exported to Southeast Asia and developed countries and regions, and enjoys a high reputation among customers at home and abroad. The company attaches importance to the development of science and technology and new products, pays attention to the cultivation of talents, and works closely with many colleges and universities and scientific research institutions to lay the foundation for the sustainable development of the company. The company carries forward the enterprise spirit of "concentric, enterprising and serious", and follows the principle of "strengthening process management, creating effective mechanism, committed to continuous improvement and pursuing excellent quality" And strive to create a cooperative team, implement modern management, and make continuous contributions to the cause of human health.
Basic Information
Tax ID
9132041271689963X2
Country/Region
Jiangsu, China
Year Established
1986
Registered Capital
CNY 14.9 Million
Business Type
Manufacturing
Total Employees
100-500 people
Quality Management Certificate
-
Total Annual Revenue
-
Enterprise Ownership
Private Owned
Is This Your Own Factory
Yes
Summary Up
Nucleoside antiviral raw materials and intermediates, and sartan antihypertensive raw materials and intermediates have a large output and a wide variety in China.
PLANT LOCATION
COMPANY ALBUM
厂房大门
办公区域
生产车间
生产车间
生产车间
其他图片
其他图片
Sign In
Please enter your email address correctly
Please enter your password
Forgot Password
OR
Join Free >